13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-10-27 Event 2026-10-22 SEC 0001753926-26-002007 →

Corvus Capital Ltd. → CDT Equity Inc. CDTTW

Stake: 22.10% Shares: 1,565,080 CUSIP: 20678X700 Class: Common Stock, par value $0.0001 per share
Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 25/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%
Disqualifiers: ACTIVE_DILUTION_SHELF: Active 424B5 / S-3 shelf takedown within ±30d
  • Active Schedule 13D filer baseline
  • High conviction ownership stake (22.1%)
  • Material 8-K governance/transaction event (Item 5.02 / 1.01 / 2.01) within ±30d

Item 4 — Purpose of Transaction

"Item 4. Purpose of Transaction." of the Schedule 13D is hereby amended and restated by this Amendment No. 7 as follows: The Reporting Persons acquired the shares of Common Stock for investment purposes. Except as otherwise described herein, the Reporting Persons currently have no plans or proposals that relate to, or would result in, any of the events or transactions described in Item 4(a) through (j) of the Schedule 13D, although each Reporting Person reserves the right, at any time and from time to time, to review or reconsider its or his position and/or change its or his purpose and/or formulate plans or proposals with respect thereto. The Reporting Persons intend to review from time to time their investment in the Issuer and the Issuer's business affairs, financial position, performance and other investment considerations. The Reporting Persons may from time to time engage in discussions with the Issuer, its directors and officers, other stockholders of the Issuer and other persons on matters that relate to the management, operations, business, assets, capitalization, financial condition, strategic plans, governance and the future of the Issuer and/or its subsidiaries. Based upon such review and discussions, as well as general economic, market and industry conditions and prospects and the Reporting Persons' liquidity requirements and investment considerations, and subject to the limitations in the agreements described above, the Reporting Persons may consider additional courses of action, which may include, in the future, formulating plans or proposals regarding the Issuer and/or its subsidiaries, including possible future plans or proposals concerning events or transactions of the kind described in Item 4(a) through (j) of the Schedule 13D.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
13 13D/G filings on this issuer
12 other filings besides this one
Filer Track Record
5 filings by this filer
4 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 2.80
100,519 shares short · -0.3% vs prior

Other 13D/G Filings on CDT Equity Inc.

FiledFormFilerStakeShares
2026-10-07 SCHEDULE 13G Primary Development Fund (Cayman) SPC - E3 Fund SP — — view →
2026-09-09 SCHEDULE 13G Wigglesworth Craig Stuart — — view →
2026-09-02 SCHEDULE 13D/A Corvus Capital Ltd. — 5,693,706 view →
2026-09-02 SCHEDULE 13G Taylor Mark Andrew — — view →
2026-08-21 SCHEDULE 13G Primary Development Fund (Cayman) SPC - E3 Fund SP — — view →
2026-08-21 SCHEDULE 13G Primary Development Fund (Cayman) SPC - E3 Fund SP — — view →
2026-06-23 SCHEDULE 13D/A Taylor Mark Andrew — 0 view →
2026-06-05 SCHEDULE 13G Ascent Partners Fund LLC — — view →
2026-05-20 SCHEDULE 13G Nirland Ltd — — view →
2026-05-14 SCHEDULE 13D/A Corvus Capital Ltd. — 257,166 view →
2025-07-31 SCHEDULE Corvus Capital Ltd. 6.00% 174,993 view →
2024-09-19 SC Corvus Capital Ltd. — — view →

Other Filings by Corvus Capital Ltd.

FiledFormIssuerStakeShares
2026-09-02 SCHEDULE 13D/A CDT Equity Inc. — 5,693,706 view →
2026-05-14 SCHEDULE 13D/A CDT Equity Inc. CDTTW — 257,166 view →
2025-07-31 SCHEDULE CONDUIT PHARMACEUTICALS INC. CDTTW 6.00% 174,993 view →
2024-09-19 SC CONDUIT PHARMACEUTICALS INC. CDTTW — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →